• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瓣膜性心脏病负担,1990-2017 年:来自 2017 年全球疾病负担研究的结果。

Burden of valvular heart disease, 1990-2017: Results from the Global Burden of Disease Study 2017.

机构信息

Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine. Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, China.

出版信息

J Glob Health. 2020 Dec;10(2):020404. doi: 10.7189/jogh.10.020404.

DOI:10.7189/jogh.10.020404
PMID:33110570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568921/
Abstract

BACKGROUND

Valvular heart disease (VHD) is expected to cause an increase in public-health problems in the coming years, especially in elderly populations. We aim to estimate the incidence, mortality, and burden of VHD, by age, from 1990 to 2017 in 195 countries and territories.

METHODS

We estimated the incidence, mortality, and burden of VHD based on the Global Burden of Disease Study 2017. All metrics are presented with their 95% uncertainty intervals (UIs). The Socio-demographic Index was used to identify whether developmental status correlates with health outcomes.

RESULTS

The global incidence of rheumatic heart disease (RHD) decreased by 8.67% between 1990 and 2017, while that of non-rheumatic VHD (NRVHD) increased by 45.10%. There was a 54.00% decrease in age-standardized death rate (ASDR) for RHD, but a small and non-significant decrease (-3.00%) in the ASDR for NRVHD. The global age-standardized disability-adjusted life years (DALY) rate of RHD decreased by 53.52%, while there was a 12.62% reduction in the age-standardized DALY rate of NRVHD.

CONCLUSIONS

The burden from different VHDs demonstrated a diverse change at a global level between 1990 and 2017. Although RHD burden has an obvious means of mitigation, a substantially high incidence of NRVHD was observed over this time period, especially in the elderly, which may lead to high health care costs and signify the potential for even higher costs in the future.

摘要

背景

预计在未来几年,瓣膜性心脏病(VHD)将导致公共卫生问题增加,尤其是在老年人群中。我们旨在评估 195 个国家和地区 1990 年至 2017 年期间按年龄划分的 VHD 发病率、死亡率和负担。

方法

我们根据 2017 年全球疾病负担研究估计了 VHD 的发病率、死亡率和负担。所有指标均以 95%置信区间(UI)表示。社会人口指数用于确定发展状况是否与健康结果相关。

结果

1990 年至 2017 年期间,风湿性心脏病(RHD)的全球发病率下降了 8.67%,而非风湿性 VHD(NRVHD)的发病率则上升了 45.10%。RHD 的年龄标准化死亡率(ASDR)下降了 54.00%,但 NRVHD 的 ASDR 略有下降(-3.00%)且无统计学意义。RHD 的全球年龄标准化残疾调整生命年(DALY)率下降了 53.52%,而 NRVHD 的年龄标准化 DALY 率则下降了 12.62%。

结论

1990 年至 2017 年期间,全球不同 VHD 的负担呈现出不同的变化趋势。尽管 RHD 的负担有明显的减轻趋势,但在此期间 NRVHD 的发病率仍然很高,尤其是在老年人中,这可能导致医疗保健费用增加,并预示着未来可能会有更高的费用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/17d74c483a3d/jogh-10-020404-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/c8457ddf067a/jogh-10-020404-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/dabef84533c4/jogh-10-020404-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/c0d8831fc8b5/jogh-10-020404-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/17d74c483a3d/jogh-10-020404-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/c8457ddf067a/jogh-10-020404-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/dabef84533c4/jogh-10-020404-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/c0d8831fc8b5/jogh-10-020404-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b437/7568921/17d74c483a3d/jogh-10-020404-F4.jpg

相似文献

1
Burden of valvular heart disease, 1990-2017: Results from the Global Burden of Disease Study 2017.瓣膜性心脏病负担,1990-2017 年:来自 2017 年全球疾病负担研究的结果。
J Glob Health. 2020 Dec;10(2):020404. doi: 10.7189/jogh.10.020404.
2
Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: Results from the Global Burden of Disease study 2019.全球、区域和国家非风湿性瓣膜性心脏病的发病率、死亡率和伤残调整生命年,以及 1990 年至 2019 年的趋势分析:来自 2019 年全球疾病负担研究的结果。
Asian Cardiovasc Thorac Ann. 2023 Oct;31(8):706-722. doi: 10.1177/02184923231200695. Epub 2023 Sep 7.
3
Analysis and comparison of the trends in burden of rheumatic heart disease in China and worldwide from 1990 to 2019.分析和比较 1990 年至 2019 年期间中国和全球风湿性心脏病负担的趋势。
BMC Cardiovasc Disord. 2023 Oct 24;23(1):517. doi: 10.1186/s12872-023-03552-w.
4
The global burden and trends of four major types of heart disease, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球 1990-2019 年四类主要心脏病的负担和趋势:2019 年全球疾病负担研究的系统分析。
Public Health. 2023 Jul;220:1-9. doi: 10.1016/j.puhe.2023.04.005. Epub 2023 May 12.
5
Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019.风湿性心脏病是一种被忽视的疾病,相对于其在全球的负担:来自 2019 年全球疾病负担的研究结果。
J Am Heart Assoc. 2022 Jul 5;11(13):e025284. doi: 10.1161/JAHA.122.025284. Epub 2022 Jun 22.
6
Burden and Temporal Trends of Valvular Heart Disease-Related Heart Failure From 1990 to 2019 and Projection Up to 2030 in Group of 20 Countries: An Analysis for the Global Burden of Disease Study 2019.20 国集团 1990 年至 2019 年期间与瓣膜性心脏病相关的心衰负担和时间趋势,以及对 2030 年的预测:2019 年全球疾病负担研究分析。
J Am Heart Assoc. 2024 Oct 15;13(20):e036462. doi: 10.1161/JAHA.124.036462. Epub 2024 Oct 11.
7
The burden of rheumatic heart disease in the Middle East and North Africa region, 1990-2019.1990-2019 年中东和北非地区风湿性心脏病负担。
Arch Cardiovasc Dis. 2023 Dec;116(12):542-554. doi: 10.1016/j.acvd.2023.09.005. Epub 2023 Oct 6.
8
Global burden of rheumatic heart disease: trends from 1990 to 2019.风湿性心脏病全球负担:1990 年至 2019 年趋势。
Arthritis Res Ther. 2022 Jun 11;24(1):138. doi: 10.1186/s13075-022-02829-3.
9
Changing trends of the disease burden of non-rheumatic valvular heart disease in China from 1990 to 2019 and its predictions: Findings from global burden of disease study.1990年至2019年中国非风湿性心脏瓣膜病疾病负担的变化趋势及其预测:全球疾病负担研究的结果
Front Cardiovasc Med. 2023 Jan 19;9:912661. doi: 10.3389/fcvm.2022.912661. eCollection 2022.
10
Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990-2017.非风湿性瓣膜性心脏病的全球和区域负担及护理质量:1990-2017 年全球疾病负担的系统分析。
Int J Qual Health Care. 2022 Apr 22;34(2). doi: 10.1093/intqhc/mzac026.

引用本文的文献

1
Serum metabolic profiling in rheumatic heart disease and degenerative aortic stenosis.风湿性心脏病和退行性主动脉瓣狭窄的血清代谢谱分析
Sci Rep. 2025 Aug 26;15(1):31470. doi: 10.1038/s41598-025-03149-7.
2
Global, regional, and national burden of non-rheumatic valvular heart disease and Its projections to 2035: comprehensive analysis of the global burden of disease study 2019.非风湿性心脏瓣膜病的全球、区域和国家负担及其到2035年的预测:全球疾病负担研究2019的综合分析
Front Cardiovasc Med. 2025 Aug 1;12:1445024. doi: 10.3389/fcvm.2025.1445024. eCollection 2025.
3
The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.

本文引用的文献

1
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
2
Development of calcific aortic valve disease: Do we know enough for new clinical trials?钙化性主动脉瓣疾病的发生发展:我们对新临床试验的认识是否足够?
J Mol Cell Cardiol. 2019 Jul;132:189-209. doi: 10.1016/j.yjmcc.2019.05.016. Epub 2019 May 25.
3
A comprehensive study capturing vision loss burden in Pakistan (1990-2025): Findings from the Global Burden of Disease (GBD) 2017 study.
人工智能对女性心血管疾病护理的影响。
Curr Cardiol Rep. 2025 Jun 20;27(1):98. doi: 10.1007/s11886-025-02250-7.
4
Characteristics and Problems of Rheumatic Heart Disease in Indonesia: The Ina-RHD Multicenter Study.印度尼西亚风湿性心脏病的特征与问题:印尼风湿性心脏病多中心研究
JACC Asia. 2025 Sep;5(9):1171-1183. doi: 10.1016/j.jacasi.2025.03.010. Epub 2025 May 13.
5
Effects of a Cloud-Based Synchronous Telehealth Program on Valvular Regurgitation Regression: Retrospective Study.基于云的同步远程医疗计划对瓣膜反流消退的影响:回顾性研究。
J Med Internet Res. 2025 Apr 23;27:e68929. doi: 10.2196/68929.
6
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.首个心脏瓣膜病结局测量国际联盟(ICHOM)心脏瓣膜病报告结局标准数据集:从以器械为中心的结局向以患者为中心的结局转变:由心脏瓣膜协会(HVS)协调的多学会工作组制定,成员包括美国心脏协会(AHA)、美国心脏病学会(ACC)、欧洲心胸外科学会(EACTS)、欧洲心脏病学会(ESC)、胸外科医师学会(STS)、澳大利亚和新西兰心脏与胸外科医师学会(ANZSCTS)、国际应用心血管生物学学会(ISACB)、国际微创心胸外科学会(ISMICS)、南非心脏协会(SHA)、心脏瓣膜之声组织以及全球心脏中心。
Ann Thorac Surg Short Rep. 2025 Feb 17;3(1):71-85. doi: 10.1016/j.atssr.2024.05.005. eCollection 2025 Mar.
7
Primary regional disparities in clinical characteristics, treatments, and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China: Insights from the China-VHD Study.中国46家三级医院一项典型设计的瓣膜性心脏病研究中临床特征、治疗及结局的主要地区差异:来自中国瓣膜性心脏病(China-VHD)研究的见解
Chin Med J (Engl). 2025 Apr 20;138(8):937-946. doi: 10.1097/CM9.0000000000003570. Epub 2025 Mar 18.
8
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes.首个心脏瓣膜病结局测量国际联盟(ICHOM)标准数据集:从以设备为中心的结局向以患者为中心的结局转变。
Innovations (Phila). 2025 Mar-Apr;20(2):133-147. doi: 10.1177/15569845241269309. Epub 2025 Feb 19.
9
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes: Developed by a multisociety taskforce coordinated by the Heart Valve Society (HVS) including the American Heart Association (AHA), the American College of Cardiology (ACC), the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology (ESC), The Society of Thoracic Surgeons (STS), the Australian & New Zealand Society of Cardiac & Thoracic Surgeons (ANZSCTS), the International Society for Applied Cardiovascular Biology (ISACB), the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), the South African Heart Association (SHA), Heart Valve Voice, and Global Heart Hub.首个心脏瓣膜病结局测量国际联盟(ICHOM)心脏瓣膜病报告结局标准数据集:从以器械为中心的结局向以患者为中心的结局转变:由心脏瓣膜协会(HVS)协调的多学会工作组制定,该工作组包括美国心脏协会(AHA)、美国心脏病学会(ACC)、欧洲心胸外科学会(EACTS)、欧洲心脏病学会(ESC)、胸外科医师学会(STS)、澳大利亚和新西兰心脏与胸外科医师学会(ANZSCTS)、国际应用心血管生物学学会(ISACB)、国际微创心胸外科学会(ISMICS)、南非心脏协会(SHA)、心脏瓣膜之声和全球心脏中心。
JACC Adv. 2025 Apr;4(4):101059. doi: 10.1016/j.jacadv.2024.101059. Epub 2025 Feb 17.
10
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes.首个心脏瓣膜病结局测量国际联盟(ICHOM)标准数据集:从以设备为中心的结局向以患者为中心的结局转变。
Eur J Cardiothorac Surg. 2025 Feb 4;67(2). doi: 10.1093/ejcts/ezae254.
一项全面研究揭示了巴基斯坦的视力丧失负担(1990-2025 年):来自 2017 年全球疾病负担研究的发现。
PLoS One. 2019 May 3;14(5):e0216492. doi: 10.1371/journal.pone.0216492. eCollection 2019.
4
Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2017 Study.疾病、伤害与儿童和青少年健康相关风险因素,1990 年至 2017 年:来自 2017 年全球疾病、伤害与风险因素负担研究的发现。
JAMA Pediatr. 2019 Jun 1;173(6):e190337. doi: 10.1001/jamapediatrics.2019.0337. Epub 2019 Jun 3.
5
Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家 1990 年至 2017 年饮食风险对健康的影响:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 May 11;393(10184):1958-1972. doi: 10.1016/S0140-6736(19)30041-8. Epub 2019 Apr 4.
6
Clinical, sonographic characteristics and long-term prognosis of valvular heart disease in elderly patients.老年患者心脏瓣膜病的临床、超声特征及长期预后
J Geriatr Cardiol. 2019 Jan;16(1):33-41. doi: 10.11909/j.issn.1671-5411.2019.01.007.
7
Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.2017 年流感导致的下呼吸道感染所致死亡率、发病率和住院治疗负担:2017 年全球疾病负担研究分析。
Lancet Respir Med. 2019 Jan;7(1):69-89. doi: 10.1016/S2213-2600(18)30496-X. Epub 2018 Dec 12.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
9
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
10
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.